Zenas BioPharma to present at upcoming healthcare investor conferences
Zenas BioPharma, Inc. (NASDAQ:ZBIO) said it will present at upcoming healthcare investor conferences.
WALTHAM, Mass., Sept.
04, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) NASDAQ:ZBIO, a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and…